Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 3
1959 2
1960 1
1961 1
1963 1
1966 2
1968 1
1969 1
2001 1
2003 1
2005 2
2006 3
2007 5
2008 5
2009 1
2010 2
2011 1
2012 3
2013 4
2014 1
2015 1
2016 1
2017 1
2018 3
2020 4
2021 1
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DEJ, Dörffel Y, Gordon SC, Harrison SA, Kremer AE, Mayo MJ, Thuluvath PJ, Levy C, Swain MG, Neff GW, Sheridan DA, Stanca CM, Berg CP, Goel A, Shiffman ML, Vierling JM, Boudes P, Steinberg A, Choi YJ, McWherter CA. Bowlus CL, et al. Among authors: stanca cm. J Hepatol. 2022 Aug;77(2):353-364. doi: 10.1016/j.jhep.2022.02.033. Epub 2022 Mar 30. J Hepatol. 2022. PMID: 35367282 Free article. Clinical Trial.
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS, Stanca CM, Figueroa Diaz V, Yuan S, Dagher NN, Sarkar SA, Theise ND, Kim S, Shanbhogue K, Jacobson IM. Faruqui S, et al. Among authors: stanca cm. Am J Gastroenterol. 2021 Jul 1;116(7):1414-1425. doi: 10.14309/ajg.0000000000001264. Am J Gastroenterol. 2021. PMID: 33993134
Isolated iliac artery aneurysms: a single-centre experience.
Fossaceca R, Guzzardi G, Cerini P, Divenuto I, Stanca C, Parziale G, Brustia P, Carriero A. Fossaceca R, et al. Among authors: stanca c. Radiol Med. 2015 May;120(5):440-8. doi: 10.1007/s11547-014-0468-y. Epub 2014 Oct 28. Radiol Med. 2015. PMID: 25348140
Transplantation trends in primary biliary cirrhosis.
Lee J, Belanger A, Doucette JT, Stanca C, Friedman S, Bach N. Lee J, et al. Among authors: stanca c. Clin Gastroenterol Hepatol. 2007 Nov;5(11):1313-5. doi: 10.1016/j.cgh.2007.07.015. Epub 2007 Sep 27. Clin Gastroenterol Hepatol. 2007. PMID: 17900996
52 results